Silence Therapeutics plc
SEC CIK 1479615 · SLN · last insider filing 2026-02-13
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mcinerney Timothy | Director | filed 2025 - 2026 |
| Lemus David | Director | filed 2025 - 2026 |
| Hellums Rhonda Lynette | Director · Chief Financial Officer | filed 2025 - 2026 |
| Ede-Golightly James | Director | filed 2025 - 2026 |
| Ross Iain | Director · Interim PEO | filed 2025 - 2025 |
| Tooman Craig A | Director · President and CEO | filed 2025 - 2025 |
| Davidson Michael H. | Director | filed 2025 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Romano Steven J. | EVP and Chief R&D Officer | filed 2025 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.